# US 2026/0062397 A1 · 2-diarylmethyl-4-aminotetrahydropyran derivatives and related compounds as anticancer, antiinflammatory, antifibrotic and neuroprotective agents

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0062397 A1
- Document ID: US20260062397A1
- Status: Published application
- Kind: A1
- Application number: 19/311,983
- Filed: 2025-08-27
- Published: 2026-03-05
- Earliest claimed: 2021-08-18
- Assignees: Atux Iskay LLC
- Applicants: Atux Iskay LLC
- Inventors: Michael Ohlmeyer
- Web page: https://patentgrep.com/patent/US20260062397A1

## CPC

- C07D 309/14: Nitrogen atoms not forming part of a nitro radical
- A61K 31/351: not condensed with another ring
- A61K 31/451: having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
- C07D 211/58: attached in position 4
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

2-diarylmethyl-4-aminotetrahydropyran derivatives are disclosed. The compounds include the following genus: or a pharmaceutically acceptable salt thereof. The compounds activate cellular PP2A, suppress oncogenic kinase signaling and negatively regulate MYC and MYCN in cancer. The compounds also induce FOXO transcription factor translocation to the nucleus by modulating PP2A and, as a consequence, exhibit anti-proliferative effects. They are useful in the treatment of a variety of disorders, including as a monotherapy in cancer treatment, or used in combination with other drugs to restore sensitivity to chemotherapy where resistance has developed.

## Claims

### Claim 1

A compound, having a formula selected from:

### Claim 2 (depends on 1)

A composition, comprising the compound of claim 1.
